Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Ting Zhan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0622-7890; OpenAlex author ID A5020823421. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 11

  1. Erratum: Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ. Co-author DOI 10.1016/j.omtn.2026.102831↗
  2. The RASSF1C-HIF-1α axis drives macrophage lipid metabolism to promote pancreatic cancer. Co-author DOI 10.1038/s41419-026-08609-0↗
  3. ILF3 mediates lipid metabolism to promote pancreatic cancer development by regulating CPT1A-activated PPARa signaling pathway. Co-author DOI 10.1016/j.bbadis.2025.167919↗
  4. Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regul… Co-author DOI 10.1002/ctm2.1799↗
  5. Erratum: miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer [Corrigendum]. Co-author DOI 10.2147/cmar.s387344↗
  6. miR-324-5p Contributes to Cell Proliferation and Apoptosis in Pancreatic Cancer by Targeting KLF3. Co-author DOI 10.1016/j.omto.2020.07.011↗
  7. MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L. Co-author DOI 10.1177/1533033820945801↗
  8. miR-455-3p Functions as a Tumor Suppressor by Restraining Wnt/β-Catenin Signaling via TAZ in Pancreatic Cancer. Co-author DOI 10.2147/cmar.s235794↗
  9. Downregulation of MicroRNA-455-3p Links to Proliferation and Drug Resistance of Pancreatic Cancer Cells via Targeting TAZ. Co-author DOI 10.1016/j.omtn.2017.12.002↗
  10. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Co-author DOI 10.1093/carcin/bgy074↗
  11. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Co-author DOI 10.1002/ijc.29070↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaodong Huang · 8 shared papers, 2018–2025 · strength 1.03
  2. Tian Xia · 8 shared papers, 2018–2025 · strength 1.03
  3. Xiaoli Chen · 6 shared papers, 2018–2026 · strength 0.74
  4. Yadong Zhang · 1 shared paper, 2026 · strength 0.33
  5. Xiaodong Huang · 1 shared paper, 2026 · strength 0.27
  6. Yu Ding · 2 shared papers, 2018–2020 · strength 0.19
  7. Yi-Yuan Wan · 2 shared papers, 2018–2020 · strength 0.18
  8. Wei Chen · 1 shared paper, 2022 · strength 0.14
  9. Zheng Han · 1 shared paper, 2022 · strength 0.14
  10. Yadong Zhang · 1 shared paper, 2020 · strength 0.10
  11. Yadong Zhang · 1 shared paper, 2018 · strength 0.09
  12. Zhongxin Lu · 1 shared paper, 2018 · strength 0.07
  13. Fei Wang · 1 shared paper, 2015 · strength 0.05
  14. Yujuan Zhang · 1 shared paper, 2015 · strength 0.05
  15. Wei Cui · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.